当前位置:首页 > 报告详情

THERMOFISHER-TMO-Final-JPM-Presentation-as-of-01-08-26.pdf

上传人: 明**** 编号:1069800 2026-01-17 26页 2.19MB

1、The world leader in serving scienceThe world leader in serving scienceMarc N.CasperChairman,President and Chief Executive OfficerJ.P.Morgan Healthcare ConferenceJanuary 13,20261Safe Harbor/Non-GAAP Measures2Various remarks that we may make in the following presentation about the companys future expe

2、ctations,plans and prospects constitute forward-looking statements for purposes of the safe harbor provisions under The PrivateSecurities LitigationReformAct of 1995,includingstatementsaboutfuturerevenueandfinancialresults.Forward-lookingstatementsarebasedon current expectationsandassumptionsthatare

3、 subject torisks anduncertainties,andareoftenidentifiedbywordssuchas“expects,”“anticipates,”“intends,”“plans,”“believes,”“seeks,”“estimates,”“may,”“will,”“should,”orsimilarexpressionsorwordswithsimilarmeanings.Actualresultsmaydiffermateriallyfromthoseindicated bytheseforward-lookingstatementsas ares

4、ultofvarious important factors,includingthosediscussedinour most recent reports onForm 10-K andForm10-Q,under thecaption“Risk Factors.”Thesefilings areonfilewiththe Securities andExchangeCommissionand available inthe“Investors”sectionof our websiteunder theheading“SEC Filings.”Forward-lookingstateme

5、ntscontained inthis presentationarebased onourcurrentexpectationsandspeakonlyasofthedateofthispresentation.Whilewemayelecttoupdateforward-lookingstatementsatsomepointinthefuture,wespecificallydisclaimanyobligationtodoso,intheeventofnewinformation,futuredevelopmentsorotherwise,exceptasrequiredbylaw.D

6、uringthis presentation,we will bereferring tocertainfinancialmeasuresnotpreparedinaccordance with generallyacceptedaccountingprinciples,or GAAP,includingadjustedEPS,freecashflow,andorganic revenuegrowth.Thenon-GAAP financial measures of Thermo Fishers results of operations and cash flows included in

word格式文档无特别注明外均可编辑修改,预览文件经过压缩,下载原文更清晰!
三个皮匠报告文库所有资源均是客户上传分享,仅供网友学习交流,未经上传用户书面授权,请勿作商用。
1. **公司定位与业绩**:Thermo Fisher Scientific是全球科学服务领导者,2025年营收达440亿美元,调整后EPS为7.38美元,自由现金流25亿美元,十年CAGR分别为10%、12%、11%。 2. **增长战略**:通过并购(如9亿美元收购Clario)和资本部署(30亿美元回购、6亿美元分红)强化竞争地位,2025年完成40亿美元收购(Solventum、Sanofi工厂等)。 3. **市场与运营**:服务270亿美元市场,制药与生物科技占56%营收;通过PPI业务系统提升生产力,2025年额外节省3亿美元成本。 4. **创新与CSR**:推出Orbitrap、Krios 5等创新产品;STEM教育覆盖18万学生,56%电力来自可再生能源,目标2050年净零排放。 5. **2026年目标**:延续增长策略,推进AI应用,交付并购协同效应,强化股东价值。
**增长策略如何?** **创新成果有哪些?** **资本部署计划?**
客服
商务合作
小程序
服务号
折叠